Skip to main content
Clinical Trials/IRCT20210608051515N2
IRCT20210608051515N2
Completed
Phase 2

Evaluation of the Effectiveness of Antidepressant Agents, Venlafaxine Versus Sertraline in Patients with Epilepsy and Depression

Tehran University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Definite Diagnosis of Epilepsy based on Clinical Findings and Neurologist View
  • Positive Evaluation of Depression based on NDDI\-E Questionnaire
  • Clinical Diagnosis of Moderate to Severe Depression Using Hamilton Depression Scale

Exclusion Criteria

  • Suicide Attempt in Recent Year
  • Alcohol or Substance Abuse
  • History of a Complex Mood Disorder e.g. Bipolar Disorder
  • Other Accompanying Neurological Disease
  • Evidence of Hypersensitivity to SSRIs
  • Hypertension
  • Major Kidney or Liver Dysfunction
  • Active Hemorrhage
  • Pregnancy and Breast\-feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials